Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Molecular Immunology
|
October 19, 2004
Humanization and epitope mapping of the H23 anti-MUC1 monoclonal antibody reveals a dual epitope specificity
Yariv Mazor, Iafa Keydar, Itai Benhar
Journal of Immunological Methods
|
March 6, 2007
Antibody internalization studied using a novel IgG binding toxin fusion
Yariv Mazor, Itay Barnea, Iafa Keydar, et al.
Cancer Letters
|
December 15, 2004
The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors
Elina Azenshtein, Tsipi Meshel, Sima Shina, et al.
Molecular Cancer
|
November 7, 2006
MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression
Joseph Z Zaretsky, Itay Barnea, Yael Aylon, et al.
The Israel Medical Association Journal : IMAJ
|
November 29, 2002
Breast carcinoma: a report on the potential usage of the CC chemokine RANTES as a marker for a progressive disease
Nely Wigler, Sima Shina, Ofer Kaplan, et al.
Neoplasia (New York, N.Y.)
|
June 3, 2008
Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker
Maya Golan, Amnon Hizi, James H Resau, et al.
Cancer Research
|
February 28, 2002
The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity
Elina Azenshtein, Galia Luboshits, Sima Shina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2006
The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients
Neora Yaal-Hahoshen, Sima Shina, Leonor Leider-Trejo, et al.
Cancer Research
|
November 3, 2004
A unique mucin immunoenhancing peptide with antitumor properties
Lynn M Herbert, Joseph F Grosso, Mantley Dorsey, et al.
Cytokine
|
September 16, 2008
Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions
Gali Soria, Neora Yaal-Hahoshen, Elina Azenshtein, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Molecular Immunology
|
October 19, 2004
Humanization and epitope mapping of the H23 anti-MUC1 monoclonal antibody reveals a dual epitope specificity
Yariv Mazor, Iafa Keydar, Itai Benhar
Journal of Immunological Methods
|
March 6, 2007
Antibody internalization studied using a novel IgG binding toxin fusion
Yariv Mazor, Itay Barnea, Iafa Keydar, et al.
Cancer Letters
|
December 15, 2004
The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors
Elina Azenshtein, Tsipi Meshel, Sima Shina, et al.
Molecular Cancer
|
November 7, 2006
MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression
Joseph Z Zaretsky, Itay Barnea, Yael Aylon, et al.
The Israel Medical Association Journal : IMAJ
|
November 29, 2002
Breast carcinoma: a report on the potential usage of the CC chemokine RANTES as a marker for a progressive disease
Nely Wigler, Sima Shina, Ofer Kaplan, et al.
Neoplasia (New York, N.Y.)
|
June 3, 2008
Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker
Maya Golan, Amnon Hizi, James H Resau, et al.
Cancer Research
|
February 28, 2002
The CC chemokine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity
Elina Azenshtein, Galia Luboshits, Sima Shina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 11, 2006
The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients
Neora Yaal-Hahoshen, Sima Shina, Leonor Leider-Trejo, et al.
Cancer Research
|
November 3, 2004
A unique mucin immunoenhancing peptide with antitumor properties
Lynn M Herbert, Joseph F Grosso, Mantley Dorsey, et al.
Cytokine
|
September 16, 2008
Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions
Gali Soria, Neora Yaal-Hahoshen, Elina Azenshtein, et al.
Page
of 2